Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia

PHASE4RecruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

November 17, 2023

Primary Completion Date

May 31, 2025

Study Completion Date

August 31, 2025

Conditions
Leukaemia (Acute)Acute Lymphoblastic Leukemia
Interventions
DIETARY_SUPPLEMENT

Dietary modification

Patients will follow Mediterranean Diet (MD), this diet is characterized by a high intake of vegetables, fruit, whole cereals, legumes, nuts, and fish and a low intake of red meat and homemade desserts. The main added fat was extra virgin olive oil, with 35-40% kcal from fat (\<10% from saturated fat), 40-44% kcal from carbohydrate, and 20% kcal from protein

DIETARY_SUPPLEMENT

Supplementation of omega 3 fatty acids

Supplementation of omega 3 fatty acids ( dose based on weight: \<40 kg-450 mg/day, 40-60 kg-900 mg/day, \>60 kg-1300 mg/day)

Trial Locations (2)

11566

RECRUITING

Ain Shams University, Cairo

RECRUITING

Faculty of Medicine Ain Shams Research Institute- Clinical Research Center (MASRI-CRC), Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER